UK's private obesity drug market choosing Lilly's Mounjaro over Wegovy | REUTERS [1gtjbw_pgk4]
UK's private obesity drug market choosing Lilly's Mounjaro over Wegovy | REUTERS [1gtjbw_pgk4]
| 1h 28m 28s | Video has closed captioning.
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the US drugmaker is gaining ground on its European rival. #News #obesity #britain #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram: #the fiber in diet pills #snopes keto gummies #new diet pills by prescription
Aired: December 22, 2024
Buy Now:
Problems Playing Video? | Closed Captioning